Global overview of the management of acute cholecystitis during the COVID-19 pandemic (CHOLECOVID study).

ABSTRACT:

Background

This study provides a global overview of the management of patients with acute cholecystitis during the initial phase of the COVID-19 pandemic.

Methods

CHOLECOVID is an international, multicentre, observational comparative study of patients admitted to hospital with acute cholecystitis during the COVID-19 pandemic. Data on management were collected for a 2-month study interval coincident with the WHO declaration of the SARS-CoV-2 pandemic and compared with an equivalent pre-pandemic time interval. Mediation analysis examined the influence of SARS-COV-2 infection on 30-day mortality.

Results

This study collected data on 9783 patients with acute cholecystitis admitted to 247 hospitals across the world. The pandemic was associated with reduced availability of

SUBMITTER: CHOLECOVID Collaborative 

PROVIDER: S-EPMC9071082 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature